Shares of Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) fell 1.6% during mid-day trading on Thursday . The stock traded as low as C$1.23 and last traded at C$1.23. 2,500 shares traded hands during trading, a decline of 95% from the average session volume of 54,721 shares. The stock had previously closed at C$1.25.
Genscript Biotech Stock Down 1.6 %
The stock has a 50-day simple moving average of C$1.37 and a 200 day simple moving average of C$1.38.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Recommended Stories
- Five stocks we like better than Genscript Biotech
- The Significance of Brokerage Rankings in Stock Selection
- Top 3 Investment Themes to Watch for in 2025
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How to Effectively Use the MarketBeat Ratings Screener
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
